Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Unquoted Biotechs -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (63)	6/13/2003 1:12:16 PM
From: tuck	Read Replies (1) \| Respond to of 253

[Sunesis -- Novel anti-cancer concept] >>Published online before print June 13, 2003 Proc. Natl. Acad. Sci. USA, 10.1073/pnas.1031631100 Biochemistry Direct activation of the apoptosis machinery as a mechanism to target cancer cells Jack T. Nguyen and James A. Wells * Sunesis Pharmaceuticals, 341 Oyster Point Boulevard, South San Francisco, CA 94080 Communicated by William F. DeGrado, University of Pennsylvania School of Medicine, Philadelphia, PA, March 20, 2003 (received for review January 31, 2003) Apoptosis plays a pivotal role in the cytotoxic activity of most chemotherapeutic drugs, and defects in this pathway provide a basis for drug resistance in many cancers. Thus the ability to restore apoptosis by using small molecules could have important therapeutic implications. Using a cell-free assay to simultaneously target multiple components of the apoptosis pathway, we identified a class of compounds that activate caspases in a cytochrome c-dependent manner and induce apoptosis in whole cells. By reconstituting the apoptosis pathway with purified proteins, we determined that these compounds promote the protein-protein association of Apaf-1 into the functional apoptosome. These compounds exert cytostatic and cytotoxic effects on a variety of cancer cell lines while having little or no activity against the normal cell lines tested. These findings suggest that direct activation of the basic apoptosis machinery may be a viable mechanism to selectively target cancer.<< Cheers, Tuck